77E-11059-51057
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-27
Registered in v-safe
-
2021-08-27
Dose 1 — Pfizer-BioNTech
- 2021-08-27
-
2021-08-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-08-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-08-30
- 2021-08-31
- 2021-09-01
- 2021-09-02
- 2021-09-10
- 2021-09-19
-
2021-09-22
Dose 2 — Pfizer-BioNTech
-
2021-09-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-27
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — day 14, dose 2MedDRA: Gestational diabetes — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gestational DiabetesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-08 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Congestion
Release 10 — day 14, dose 2
Symptoms: Gestational Diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release